10-30611971-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_183058.3(LYZL2):āc.431A>Gā(p.Asp144Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000139 in 1,614,070 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_183058.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LYZL2 | NM_183058.3 | c.431A>G | p.Asp144Gly | missense_variant | 5/5 | ENST00000647634.2 | NP_898881.3 | |
LYZL2 | XM_011519306.3 | c.490A>G | p.Thr164Ala | missense_variant | 4/4 | XP_011517608.1 | ||
LYZL2 | XR_930469.3 | n.485-4436A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LYZL2 | ENST00000647634.2 | c.431A>G | p.Asp144Gly | missense_variant | 5/5 | NM_183058.3 | ENSP00000497408.1 | |||
LYZL2 | ENST00000375318.4 | c.569A>G | p.Asp190Gly | missense_variant | 5/5 | 1 | ENSP00000364467.2 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251478Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135912
GnomAD4 exome AF: 0.000137 AC: 200AN: 1461870Hom.: 1 Cov.: 31 AF XY: 0.000139 AC XY: 101AN XY: 727234
GnomAD4 genome AF: 0.000158 AC: 24AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74346
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at